Navigation Links
Journal Article Suggests DermaClose® RC Used in Combination With VAC Therapy Can Dramatically Reduce the Need for Skin Grafting of Fasciotomy Wounds for Combat Related Trauma
Date:3/22/2012

CHANHASSEN, Minn., March 22, 2012 /PRNewswire-iReach/ -- Wound Care Technologies, Inc. (www.dermaclose.com), an emerging medical technology company, today announced the publication of an invited review article by MAJ Benjamin K. Potter, MD, LTC Brett A. Freedman, MD, and Michael S. Shuler, MD, at Walter Reed National Military Medical Center, Bethesda, MD, describing their treatment for closing extremity fasciotomy wounds using the DermaClose® RC Continuous External Tissue Expander as it applies to the treatment of traumatic war injuries.

The article entitled, "Fasciotomy Wound Management and Closure" appears in the current issue of Techniques in Orthopedics® (Volume 27, Number 1, Lippincott Williams & Wolters, www.techortho.com). The authors describe how the use of vacuum-assisted closure (V.A.C., Kinetic Concepts, Inc., San Antonio, TX) in combination with dermatotraction is their preferred method to positively influence the rate of delayed primary closure of extremity fasciotomy wounds. Paul J. Anderson, President and CEO of Wound Care Technologies, Inc. said, "Thi speer reviewed published article continues to demonstrate the significant role of continuous external tissue expansion in the treatment of traumatic injuries".

About DermaClose RC®
DermaClose® RC is a continuous external tissue expander that facilitates rapid tissue movement to reduce or re-approximate wounds. The first-of-its-kind device utilizes skin anchors and a tension controller that applies a continuous controlled dynamic pulling force and does not require additional tightening after initial application. The tension will be maintained from hours to days until desired amount of expanded tissue is achieved and the device is removed.

About Wound Care Technologies, Inc.
Wound Care Technologies, Inc. (www.woundcaretech.com) is an emerging medical device company focused on the commercialization of its novel continuous external tissue expansion technology. The DermaClose RC® is the companies initial product and is currently marketed in the United States. For further information please contact Mr. Dennis L. Davey, VP of Sales and Marketing via email at ddavey@woundcaretech.com.

Media Contact: Dennis Davey, Wound Care Technologies, Inc., 612-325-9736, Ddavey@woundcaretech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Wound Care Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses
2. Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine
3. Data Published in the Journal of the American Society of Nephrology Shows Daily Home Hemodialysis Patients with the NxStage System One Have Significantly Lower Risk of Mortality and Improved 3-Year Survival Versus Patients on Conventional Hemodialys
4. Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism
5. Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
6. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
7. National Pharmaceutical Council Debuts Column, "From Methods to Policy," In New Journal of Comparative Effectiveness Research
8. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
9. Results From Pilot Trial of PLCs RenalGuard® Published in International Journal of Cardiology
10. Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation
11. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):